Almac Licenses the Rosetta Resolver System
News Mar 30, 2006
Almac Diagnostics and Rosetta Biosoftware have announced that Almac Diagnostics (formerly ArraDx Ltd) licensed the Rosetta Resolver® system for use in the development of microarray-based approaches for diagnosing cancer and predicting therapeutic outcomes.
The Resolver system will also be used in the provision of comprehensive gene expression analysis services offered by Almac Diagnostics to academic, biotech and pharmaceutical customers.
"We are pleased to continue to expand our business by supporting cancer diagnostic research," said Yelena Shevelenko, vice president and general manager of Rosetta Biosoftware.
"The Resolver system provides a flexible platform to enable researchers to use microarray data in a large biological context, such as the development of disease-specific microarrays for diagnosing cancer."
"At Almac Diagnostics, we are dedicated to promoting discovery," said Professor Paul Harkin, CEO of Almac Diagnostics.
"Almac Diagnostics is pioneering a novel transcriptomics-based approach to develop tools, which will radically improve diagnosis and treatment of cancer."
"The Resolver system provides the comprehensive solution necessary for us to advance this type of research and realize more targeted and personalized approaches for cancer diagnosis and prognosis."
"Furthermore, our use of the Resolver system will allow all our service customers to benefit from state-of-the-art technology in gene expression data management, analysis and visualization."
Simple Test to Predict Head & Neck Cancers' Likely SpreadNews
New QUT research has shed fresh light on how head and neck cancer spreads to other organs and researchers are developing a simple blood test to tell doctors which patients are at risk of spread long before conventional imaging can.READ MORE
Life-Saving Chemical Detectors, Made With LEGO BricksNews
Potent chemical weapons can be detected by a new tool made of LEGO. A potential life-saver, which helps with decontaminationREAD MORE
Harnessing Microfluidics And a Heartbeat To Help NeonatesNews
Use of microfluidics in artificial placentas to help deliver oxygen to premature babiesREAD MORE